Diabetes
Conditions
Brief summary
The INTELLIH (brand name of the mobile health application) Diabetes Study is to understand the usage of a mobile health application, IntelliH, and connected wireless devices such as glucometer by the diabetic patients and ascertain if there are any improvements in short-term health outcomes.
Detailed description
The proposed pilot program is the first of its kind in the nation to use a product, IntelliH - Intelligent Health for All, that combines four key technologies in one platform: 1) Mobile health application (mHealth) App and web portal, 2) wireless sensors and wearable devices, 3) Secure text messaging when both sender and receiver are logged in to the system and video-based patient interaction, and 4) remote health monitoring. The purpose of this pilot program is to understand a) usage and adoption of these technologies by providers and patients, and b) document the short-term improvements in health outcomes in a diabetic population. This pilot study will follow 20 diabetic patients (Type 1 or Type 2) as they beta-test this system, and will acquire data on consented subjects over a period of six months.
Interventions
DEVICEIntelliH
IntelliH is a mobile health and a web-based software application that allows patients to enter their blood glucose, weight, medication, diet and other life-style data for review by their providers and monitor their health remotely.
Sponsors
Cedars-Sinai Medical Center
AnalyticsPlus, Inc.
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* A1c greater than or equal to 6.5%. * Age greater than or equal to 18 years. * Ability to comply with study protocol. * Available and usable internet facilities at home. * Availability and usable smart phone.
Exclusion criteria
-Inability to comply with instructions and directions.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Usage and Adoption of the smart phone based mobile health application | Six Months | Patients adoption will be assessed directly through the application and through questionnaire |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Blood glucose range maintenance and variation | Six months | Frequency of hypoglycemic, hyperglycemic, and out of recommended range events |
| Adherence to Prescribed Medication | Six months | Medication adherence rates will be measured for each medication used by patient |
Countries
United States
Contacts
Primary ContactRuchi Mathur, MD
Backup ContactLaura Sarmiento, CCRP
Outcome results
None listed